Comprehensive Management Strategies for Diabetes
The management of diabetes requires a patient-centered, multidisciplinary team approach focusing on lifestyle modifications, pharmacological interventions, and regular monitoring to prevent complications and optimize quality of life. 1
Team-Based Care Approach
- Diabetes care should be managed by a multidisciplinary team including physicians, nurses, dietitians, exercise specialists, pharmacists, dentists, podiatrists, and mental health professionals 2, 1
- Care should align with the Chronic Care Model to ensure productive interactions between a prepared proactive practice team and an informed activated patient 2
- Treatment decisions should be timely, evidence-based, and tailored to individual patient preferences, prognoses, and comorbidities 2
Initial Evaluation and Assessment
- A complete medical evaluation should classify diabetes type, detect complications, review previous treatment, and establish a management plan 1
- Laboratory tests should include HbA1c, fasting glucose, lipid profile, kidney function tests, and urine albumin-to-creatinine ratio 1
- Screen for autoimmune conditions in type 1 diabetes, such as thyroid dysfunction and celiac disease 1
- Assess for comorbidities including obesity, hypertension, dyslipidemia, and existing microvascular complications 1
Glycemic Targets and Monitoring
- Set individualized HbA1c targets based on patient's age, comorbidities, risk of hypoglycemia, and life expectancy 1
- Regular HbA1c testing (typically every 3-6 months) is recommended to assess long-term glycemic control 1
- Self-monitoring of blood glucose plays an essential role in the prevention and management of hypoglycemia 3
- Increased frequency of blood glucose monitoring is recommended for patients at higher risk for hypoglycemia and those with reduced symptomatic awareness 3
Lifestyle Management
Nutrition
- Implement medical nutrition therapy with individualized meal planning 1
- No ideal percentage of calories from carbohydrate, protein, and fat exists for all people with diabetes; macronutrient distribution should be based on individualized assessment 1
- Various eating patterns can be effective, including Mediterranean-style, DASH, plant-based, lower-fat, and lower-carbohydrate patterns 1
- Focus on weight loss (if indicated) by reducing intake of saturated fat, trans fat, and cholesterol while increasing intake of ω-3 fatty acids, viscous fiber, and plant stanols or sterols 2
Physical Activity
- Encourage at least 150 minutes of moderate-intensity aerobic activity per week, reduced sedentary time, and resistance training at least twice weekly 2, 1
- Regular physical activity improves blood glucose control, reduces cardiovascular risk factors, contributes to weight loss, and improves well-being 4
- Exercise interventions should be tailored based on individual factors including residual β-cell functionality 5
Weight Management
- For overweight/obese patients, prescribe high-intensity diet, physical activity, and behavioral therapy designed to achieve ≥5% weight loss 1
- Recommend 500-750 kcal/day energy deficit to promote weight loss 1
- Lifestyle interventions focusing on weight loss have been shown to prevent or delay the onset of type 2 diabetes in high-risk individuals 4
Pharmacologic Therapy
Type 1 Diabetes
- Most patients with type 1 diabetes should be treated with multiple-dose insulin injections or continuous subcutaneous insulin injection 2
- Patients should use insulin analogues to reduce hypoglycemia risk 2
- Patients should be educated on matching prandial insulin doses to carbohydrate intake, preprandial blood glucose levels, and anticipated activity level 2
Type 2 Diabetes
- Initiate pharmacologic therapy at diagnosis of type 2 diabetes, in addition to lifestyle therapy 1
- Metformin is the preferred initial pharmacologic agent if renal function is adequate 2, 1
- When monotherapy with a noninsulin agent at maximum tolerated dose does not achieve or maintain the HbA1c target over 3 months, a second agent should be added 2
- Consider patient factors when selecting medications, including efficacy, cost, potential side effects, weight effects, comorbidities, and risk for hypoglycemia 2
Cardiovascular Risk Factor Management
Blood Pressure Control
- Patients with diabetes and hypertension should have a blood pressure treatment goal of less than 140/90 mm Hg 2
- Lifestyle therapy should consist of weight loss, reduced-sodium diet, moderate alcohol intake, and increased physical activity 2
- Pharmacologic therapy should include either an ACE inhibitor or ARB (but not both) 2
Lipid Management
- Statin use is recommended for most persons with diabetes aged 40 years or older 2
- Lifestyle modification should be recommended to improve the lipid profile 2
- In addition to intensive lifestyle therapy, statin intensity should be based on the patient's risk profile 2
Hypoglycemia Management
- Hypoglycemia is the most common adverse reaction of all insulins 3, 6
- Early warning symptoms of hypoglycemia may be different or less pronounced under certain conditions, such as long duration of diabetes, diabetic nerve disease, or use of medications like beta-blockers 6
- Hypoglycemia may be reversed with administration of rapid-acting glucose (15-20g) 2
- Patients should be educated on situations that increase their risk for hypoglycemia, such as fasting for tests or procedures, during or after exercise, and during sleep 2
Diabetes Self-Management Education and Support (DSMES)
- Provide DSMES to all patients at diagnosis and at critical points throughout their care 1
- Education should focus on helping patients make informed self-management choices rather than simply providing information 1
- Include essential content on hypoglycemia/hyperglycemia recognition and treatment, medication administration, blood glucose monitoring, and nutritional management 1
- A patient-centered communication style that incorporates patient preferences, assesses literacy and numeracy, and addresses cultural barriers to care should be used 2
Complication Screening and Prevention
- Conduct regular screening for microvascular complications, including annual comprehensive eye examination, screening for diabetic kidney disease, and comprehensive foot examination 1
- Screen for and treat modifiable cardiovascular risk factors 1
- Provide all age-appropriate vaccinations 1
Common Pitfalls and Caveats
- Never share insulin pens, needles, or syringes between patients, even if the needle is changed, due to risk of blood-borne pathogen transmission 3
- Changes in insulin regimen (e.g., insulin strength, manufacturer, type, injection site, or method of administration) may affect glycemic control and predispose to hypoglycemia or hyperglycemia 3
- Repeated insulin injections into areas of lipodystrophy can result in hyperglycemia; sudden change in injection site to unaffected area may result in hypoglycemia 3
- Severe hypoglycemia can cause seizures, may lead to unconsciousness, and may be life-threatening 3
- Insulin requirements may change during intercurrent conditions such as illness, emotional disturbances, or other stresses 6